Back to search results

SAVI Scout MD for Localized Breast Surgery

This study is looking at a new device called SAVI Scout MD for women undergoing surgery for breast cancer. The SAVI Scout MD system uses tiny radar reflectors, instead of wires, to help surgeons find the cancer more precisely. These reflectors can be placed days or weeks before surgery. The goal is to see how accurate the SAVI Scout MD is and how easy it is for surgeons to use, which may lead to a lower chance of needing a second surgery. We are looking for adult women, 18 years or older, who have breast cancer that can be seen on imaging (sonogram, mammogram, or MRI) and are planning to have surgery. The main way we'll know if the study is successful is by measuring the successful operation rate up to 6 weeks after surgery. The current recruitment status is unclear.

Study design
This is an interventional study involving 37 women. It is designed to evaluate a new device for breast cancer surgery.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for up to 6 weeks after surgery to assess the successful operation rate.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07686250

Evaluation and Outcomes of SAVI Scout MD for Localized Breast Surgery

Recruiting
PHASE2Ages 18+InterventionalTreatment
H. Lee Moffitt Cancer Center and Research Institute
~37 participants
Updated 2026-07-30 on ClinicalTrials.gov
What's tested:SAVI Scout MD system

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Successful Operation Rate (SOR)
Measured over Up to 6 weeks.

Conditions

Breast Cancer

Explore related trials

Breast Carcinoma

Where it's being run

1 sites across 1 states
Florida1

Study leadership

  • Marie Lee, MD · PRINCIPAL_INVESTIGATOR · Moffitt Cancer Center

Who to contact

Diane Tendoh
[email protected]
813-745-4979
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adult females who are 18 years of age or older at time of signing informed consent will be eligible.
Must have ability to comprehend and the willingness to sign written informed consent for study participation.
Patients must have at least one sonographically, mammographically, or MRI identifiable in-breast malignancy and consent to undergo a surgical resection requiring bracketed localization (more than one localizing marker) at Moffitt Cancer Center. Mammographically or sonographically visible biopsy clips may be used as a localizing target.

Exclusion

Patients undergoing mastectomy for resection of the targeted lesion.
Planned excision of multiple separate sites in the ipsilateral breast.
Inability to undergo surgery at Moffitt Cancer Center.

What this trial measures

  • Successful Operation Rate (SOR)Up to 6 weeks.

    Proportion of patients achieving complete tumor resection with negative surgical margins ("no tumor on ink" or ≥2 mm for DCIS).